The Ras family GTPases (Ras, Rap1, and Rap2) and their downstream mitogen-activated protein kinases (ERK, JNK, and p38MAPK) and PI3K signaling cascades control various physiological processes. In neuronal cells, recent studies have shown that these parallel cascades signal distinct forms of AMPA-sensitive glutamate receptor trafficking during experience-dependent synaptic plasticity and adaptive behavior. Interestingly, both hypo- and hyperactivation of Ras/ Rap signaling impair the capacity of synaptic plasticity, underscoring the importance of a “happy-medium” dynamic regulation of the signaling. Moreover, accumulating reports have linked various genetic defects that either up- or down-regulate Ras/Rap signaling with several mental disorders associated with learning disability (e.g., Alzheimer’s disease, Angelman syndrome, autism, cardio-facio-cutaneous syndrome, Coffin-Lowry syndrome, Costello syndrome, Cowden and Bannayan-Riley-Ruvalcaba syndromes, fragile X syndrome, neurofibromatosis type 1, Noonan syndrome, schizophrenia, tuberous sclerosis, and X-linked mental retardation), highlighting the necessity of happy-medium dynamic regulation of Ras/Rap signaling in learning behavior. Thus, the recent advances in understanding of neuronal Ras/Rap signaling provide a useful guide for developing novel treatments for mental diseases.
Adesnik H., Nicoll RA, England PM2005. Photoinactivation of native AMPA receptors reveals their real-time trafficking. Neuron48:977-85.
2.
Allanson JE1987. Noonan syndrome. J Med Genet24:9-13.
3.
Alzheimer A.1907. Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeit Psychiatrie Psych-Gerichtliche Med64:146-8.
4.
Andrasfalvy BK, Smith MA, Borchardt T., Sprengel R., Magee JC2003. Impaired regulation of synaptic strength in hippocampal neurons from GluR1-deficient mice. J Physiol552:35-45.
5.
Angelman H.1965. ‘Puppet’ children: a report on three cases . Dev Med Child Neurol7:681-8.
6.
Aoki Y., Niihori T., Kawame H., Kurosawa K., Ohashi H., Tanaka Y., and others.2005. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet37:1038-40.
7.
Ashby MC, De La Rue SA, Ralph GS, Uney J., Collingridge GL, Henley JM2004. Removal of AMPA receptors (AMPARs) from synapses is preceded by transient endocytosis of extra-synaptic AMPARs. J Neurosci24:5172-6.
8.
Bagal AA, Kao JP, Tang CM, Thompson SM2005. Long-term potentiation of exogenous glutamate responses at single dendritic spines. Proc Natl Acad Sci U S A102:14434-9.
9.
Bagni C., Greenough WT2005. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci6:376-87.
10.
Bakker CE, Verheij C., Willemsen R., Vanderhelm R., Oerlemans F., Vermey M., and others.1994. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.Cell78:23-33.
11.
Bannayan GA1971. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol92:1-5.
12.
Beattie EC, Carroll RC, Yu X., Morishita W., Yasuda H., von Zastrow M., and others.2000. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci3:1291-300.
13.
Beaulieu JM, Gainetdinov RR, Caron MG2009. Akt/GSK3 signaling in the action of psychotropic drugs . Annu Rev Pharmacol Toxicol49:327-47.
14.
Bellone C., Luscher C.2006. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci9:636-41.
15.
Bhattacharyya S., Biou V., Xu W., Schluter O., Malenka RC2009. A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors. Nat Neurosci12:172-81.
16.
Billuart P., Bienvenu T., Ronce N., des Portes V., Vinet MC, Zemni R., and others.1998. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature392:923-6.
17.
Bleuler E.1950. Dementia praecox or the group of schizophrenias (1911) . Translated by Zinkin J. New York: International Universities Press, 1950.
18.
Bliss TV, Collingridge GL1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature361: 31-9.
19.
Bliss TV, Lomo T.1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (Lond) 232:331-56.
20.
Boda B., Alberi S., Nikonenko I., Node-Langlois R., Jourdain P., Moosmayer M., and others.2004. The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J Neurosci24:10816-25.
21.
Boehm J., Kang MG, Johnson RC, Esteban J., Huganir RL, Malinow R.2006. Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron51:213-25.
Bourneville DM1880. Sclerose tubereuse des circonvolutions cerebrales: idiotie et epilepsie hemiplegique. Arch Neurol ( Paris) 1:81-90.
24.
Braithwaite SP, Xia H., Malenka RC2002. Differential roles for NSF and GRIP/ABP in AMPA receptor cycling. Proc Natl Acad Sci U S A99:7096-101.
25.
Brown TC, Tran IC, Backos DS, Esteban JA2005. NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD . Neuron45:81-94.
26.
Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z., Brown M., Takahashi TN, and others.2005. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet42:318-21.
27.
Buzsaki G., Csicsvari J., Dragoi G., Harris K., Henze D., Hirase H.2002. Homeostatic maintenance of neuronal excitability by burst discharges in vivo. Cereb Cortex12:893-9.
28.
Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R., Bravaccio C., Trillo S., and others.2006. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A103:16834-9.
29.
Chalhoub N., Baker SJ2009. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol4:127-50.
30.
Chen AP, Ohno M., Giese KP, Kuhn R., Chen RL, Silva AJ2006. Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory. J Neurosci Res83:28-38.
31.
Chen HJ, Rojas-Soto M., Oguni A., Kennedy MB1998. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron20:895-904.
32.
Chen X., Garelick MG, Wang H., Lil V., Athos J., Storm DR2005. PI3 kinase signaling is required for retrieval and extinction of contextual memory. Nat Neurosci8:925-31.
33.
Chung HJ, Steinberg JP, Huganir RL, Linden DJ2003. Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression. Science300:1751-5.
34.
Chung HJ, Xia J., Scannevin RH, Zhang X., Huganir RL2000. Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci20:7258-67.
35.
Clayton-Smith J., Laan L.2003. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet40:87-95.
36.
Clem RL, Barth A.2006. Pathway-specific trafficking of native AMPARs by in vivo experience. Neuron49:663-70.
37.
Coffin GS, Siris E., Wegieka LC1966. Mental retardation with osteocartilaginous anomalies. Am J Dis Child112:205-13.
38.
Collingridge GL, Isaac JT, Wang YT2004. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci5:952-62.
39.
Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, and others.1997. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A94:5401-4.
40.
Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y., and others.2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature454:118-21.
41.
Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J., Ohno M., and others.2002. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature415:526-30.
42.
Costa RM, Silva AJ2003. Mouse models of neurofibromatosis type I: bridging the GAP. Trends Mol Med9:19-23.
43.
Costello JM1977. A new syndrome: mental subnormality and nasal papillomata . Aust Paediatr J13:114-8.
44.
Crino PB, Nathanson KL, Henske EP2006. The tuberous sclerosis complex. N Engl J Med355:1345-56.
45.
Cruz JC, Tsai LH2004. Cdk5 deregulation in the pathogenesis of Alzheimer’s disease. Trends Mol Med10:452-8.
46.
Cui Y., Costa RM, Murphy GG, Elgersma Y., Zhu Y., Gutmann DH, and others.2008. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell135: 549-60.
47.
Cull-Candy S., Kelly L., Farrant M.2006. Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol16:288-97.
48.
Curatolo P., Bombardieri R., Jozwiak S.2008. Tuberous sclerosis. Lancet372:657-68.
49.
Datta SR, Brunet A., Greenberg ME1999. Cellular survival: a play in three Akts. Genes Dev13:2905-27.
50.
Davies H., Bignell GR, Cox C., Stephens P., Edkins S., Clegg S., and others.2002. Mutations of the BRAF gene in human cancer. Nature417:949-54.
51.
Daw MI, Chittajallu R., Bortolotto ZA, Dev KK, Duprat F., Henley JM, and others.2000. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron28:873-86.
52.
DeKosky ST, Scheff SW1990. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol27:457-64.
53.
Delaunoy J., Abidi F., Zeniou M., Jacquot S., Merienne K., Pannetier S., and others.2001. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Hum Mutat17:103-16.
54.
Derkach VA, Oh MC, Guire ES, Soderling TR2007. Regulatory mechanisms of AMPA receptors in synaptic plasticity . Nat Rev Neurosci8:101-13.
55.
D’Hooge R., Nagels G., Franck F., Bakker CE, Reyniers E., Storm K., and others.1997. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience76:367-76.
56.
Dobkin C., Rabe A., Dumas R., El Idrissi A., Haubenstock H., Brown WT2000. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience100: 423-9.
57.
Dolen G., Osterweil E., Rao BS, Smith GB, Auerbach BD, Chattarji S., and others.2007. Correction of fragile X syndrome in mice. Neuron56:955-62.
58.
Durand CM, Betancur C., Boeckers TM, Bockmann J., Chaste P., Fauchereau F., and others.2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet39:25-7.
59.
Ehlers MD, Heine M., Groc L., Lee MC, Choquet D.2007. Diffusional trapping of GluR1 AMPA receptors by input-specific synaptic activity. Neuron54:447-60.
60.
Ehninger D., Li W., Fox K., Stryker MP, Silva AJ2008. Reversing neurodevelopmental disorders in adults. Neuron60:950-60.
61.
Eng C.2003. PTEN: one gene, many syndromes. Hum Mutat22:183-98.
62.
English JD, Sweatt JD1997. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem272:19103-6.
63.
Esteban JA, Shi SH, Wilson C., Nuriya M., Huganir RL, Malinow R.2003. PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci6:136-43.
64.
Estep AL, Tidyman WE, Teitell MA, Cotter PD, Rauen KA2006. HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy . Am J Med Genet A140:8-16.
65.
European Chromosome 16 Tuberous Sclerosis Consortium .1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell75:1305-15.
66.
Ferrer I., Gomez-Isla T., Puig B., Freixes M., Ribe E., Dalfo E., and others.2005. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer’s disease and tauopathies. Curr Alzheimer Res2:3-18.
67.
Frankland PW, Wang Y., Rosner B., Shimizu T., Balleine BW, Dykens EM, and others.2004. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry9:417-25.
68.
Froemke RC, Poo MM, Dan Y.2005. Spike-timing-dependent synaptic plasticity depends on dendritic location. Nature434:221-5.
69.
Fujii S., Saito K., Miyakawa H., Ito K., Kato H.1991. Reversal of long-term potentiation (depotentiation) induced by tetanus stimulation of the input to CA1 neurons of guinea pig hippocampal slices. Brain Res555:112-22.
70.
Gallo KA, Johnson GL2002. Mixed-lineage kinase control of JNK and p38 MAPK pathways . Nat Rev Mol Cell Biol3:663-72.
71.
Gardner SM, Trussell LO, Oertel D.2001. Correlation of AMPA receptor subunit composition with synaptic input in the mammalian cochlear nuclei. J Neurosci21:7428-37.
72.
Geschwind DH2009. Advances in autism. Annu Rev Med60: 367-80.
73.
Goffin A., Hoefsloot LH, Bosgoed E., Swillen A., Fryns JP2001. PTEN mutation in a family with Cowden syndrome and autism . Am J Med Genet105:521-4.
74.
Govek EE, Newey SE, Van Aelst L.2005. The role of the Rho GTPases in neuronal development. Genes Dev19:1-49.
75.
Greger IH, Khatri L., Kong X., Ziff EB2003. AMPA receptor tetramerization is mediated by Q/R editing . Neuron40: 763-74.
76.
Grossman AW, Elisseou NM, McKinney BC, Greenough WT2006. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res1084:158-64.
Gustafson S., Zbuk KM, Scacheri C., Eng C.2007. Cowden syndrome. Semin Oncol34:428-34.
79.
Haass C., Selkoe DJ2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol8:101-12.
80.
Hall J., Romaniuk L., McIntosh AM, Steele JD, Johnstone EC, Lawrie SM2009. Associative learning and the genetics of schizophrenia . Trends Neurosci32:359-65.
81.
Hall SS, Burns DD, Lightbody AA, Reiss AL2008. Longitudinal changes in intellectual development in children with fragile X syndrome. J Abnorm Child Psychol36:927-39.
82.
Hanahan D., Weinberg RA2000. The hallmarks of cancer. Cell100:57-70.
83.
Hanssen AM, Fryns JP1995. Cowden syndrome. J Med Genet32:117-9.
84.
Harrison PJ, Weinberger DR2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry10:40-68; image 5.
Harvey CD, Yasuda R., Zhong H., Svoboda K.2008. The spread of Ras activity triggered by activation of a single dendritic spine. Science321:136-40.
87.
Hayashi Y., Shi SH, Esteban JA, Piccini A., Poncer JC, Malinow R.2000. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science287:2262-7.
88.
Heine M., Groc L., Frischknecht R., Beique JC, Lounis B., Rumbaugh G., and others.2008. Surface mobility of postsynaptic AMPARs tunes synaptic transmission. Science320:201-5.
89.
Hersey P., Bastholt L., Chiarion-Sileni V., Cinat G., Dummer R., Eggermont AM, and others.2009. Small molecules and targeted therapies in distant metastatic disease. Ann Oncol20(Suppl6):vi35-40.
90.
Hollmann M., Heinemann S.1994. Cloned glutamate receptors. Annu Rev Neurosci17:31-108.
91.
Horwood JM, Dufour F., Laroche S., Davis S.2006. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci23:3375-84.
92.
Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and others.2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron52: 831-43.
93.
Hu H., Qin Y., Bochorishvili G., Zhu Y., van Aelst L., Zhu JJ2008. Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. J Neurosci28:7847-62.
94.
Hu H., Real E., Takamiya K., Kang MG, Ledoux J., Huganir RL, and others.2007. Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell131: 160-73.
95.
Huang CC, Liang YC, Hsu KS1999. A role for extracellular adenosine in time-dependent reversal of long-term potentiation by low-frequency stimulation at hippocampal CA1 synapses. J Neurosci19:9728-38.
96.
Huang YZ, Won S., Ali DW, Wang Q., Tanowitz M., Du QS, and others.2000. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron26: 443-55.
97.
Huber KM, Gallagher SM, Warren ST, Bear MF2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A99:7746-50.
98.
Humeau Y., Gambino F., Chelly J., Vitale N.2009. X-linked mental retardation: focus on synaptic function and plasticity. J Neurochem109:1-14.
99.
Husi H., Ward MA, Choudhary JS, Blackstock WP, Grant SG2000. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci3:661-9.
100.
Irwin SA, Patel B., Idupulapati M., Harris JB, Crisostomo RA, Larsen BP, and others.2001. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet98:161-7.
101.
Isaac JT, Ashby M., McBain CJ2007. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron54:859-71.
102.
Jacquot S., Merienne K., De Cesare D., Pannetier S., Mandel JL, Sassone-Corsi P., and others.1998. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Am J Hum Genet63:1631-40.
103.
Jiang YH, Armstrong D., Albrecht U., Atkins CM, Noebels JL, Eichele G., and others.1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron21:799-811.
104.
Jonas P.2000. The time course of signaling at central glutamatergic synapses. News Physiol Sci15:83-9.
105.
Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., and others.2003. APP processing and synaptic function . Neuron37:925-37.
106.
Kandt RS, Haines JL, Smith M., Northrup H., Gardner RJ, Short MP, and others.1992. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease . Nat Genet2:37-41.
107.
Kanner L.1943. Autistic disturbances of affective contact. Nervous Child2:217-50.
Kelly A., Lynch MA2000. Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin. Neuropharmacology39:643-51.
110.
Kerchner GA, Nicoll RA2008. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci9:813-25.
111.
Kerr B., Delrue MA, Sigaudy S., Perveen R., Marche M., Burgelin I., and others.2006. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet43:401-5.
112.
Kessels HW, Kopec CD, Klein ME, Malinow R.2009. Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution. Nat Neurosci12: 888-96.
Kielland A., Bochorishvili G., Corson J., Zhang L., Rosin DL, Heggelund P., and others.2009. Activity patterns govern synapse-specific AMPA-R trafficking between deliverable and synaptic pools. Neuron62:84-101.
115.
Kim JH, Liao D., Lau LF, Huganir RL1998. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron20:683-91.
116.
Kolleker A., Zhu JJ, Schupp BJ, Qin Y., Mack V., Borchardt T., and others.2003. Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. Neuron40: 1199-212.
117.
Kraepelin E.1971. Dementia praecox and paraphrenia (1919). Translated by Barclay RM; edited by Robertson GMHuntington (NY): RE Krieger.
118.
Kumar SS, Bacci A., Kharazia V., Huguenard JR2002. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci22:3005-15.
119.
Kutsche K., Yntema H., Brandt A., Jantke I., Nothwang HG, Orth U., and others.2000. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet26:247-50.
120.
Kwiatkowski DJ, Manning BD2005. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet14 Spec No. 2:R251-8.
121.
Kwon CH, Luikart BW, Powell CM, Zhou J., Matheny SA, Zhang W., and others.2006. Pten regulates neuronal arborization and social interaction in mice. Neuron50:377-88.
122.
Kyriakis JM, Avruch J.2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev81:807-69.
123.
Lachlan KL, Lucassen AM, Bunyan D., Temple IK2007. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet44:579-85.
124.
Lai C., Xie C., McCormack SG, Chiang HC, Michalak MK, Lin X., and others.2006. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J Neurosci26:11798-806.
125.
Lanfranchi S., Cornoldi C., Drigo S., Vianello R.2009. Working memory in individuals with fragile X syndrome . Child Neuropsychol15:105-19.
126.
Lauterborn JC, Rex CS, Kramar E., Chen LY, Pandyarajan V., Lynch G., and others.2007. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci27:10685-94.
127.
Lee SH, Liu L., Wang YT, Sheng M.2002. Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD. Neuron36:661-74.
128.
Lee SH, Simonetta A., Sheng M.2004. Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons. Neuron43:221-36.
129.
Lee SJ, Escobedo-Lozoya Y., Szatmari EM, Yasuda R.2009. Activation of CaMKII in single dendritic spines during long-term potentiation. Nature458:299-304.
130.
Levitt P., Campbell DB2009. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest119:747-54.
131.
Li B., Woo RS, Mei L., Malinow R.2007. The neuregulin-1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity. Neuron54:583-97.
132.
Li W., Cui Y., Kushner SA, Brown RA, Jentsch JD, Frankland PW, and others.2005. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol15:1961-7.
133.
Liaw D., Marsh DJ, Li J., Dahia PL, Wang SI, Zheng Z., and others.1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet16:64-7.
134.
Lin CH, Yeh SH, Lu KT, Leu TH, Chang WC, Gean PW2001. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron31:841-51.
135.
Lin DT, Huganir RL2007. PICK1 and phosphorylation of the glutamate receptor 2 (GluR2) AMPA receptor subunit regulates GluR2 recycling after NMDA receptor-induced internalization. J Neurosci27:13903-8.
136.
Lin DT, Makino Y., Sharma K., Hayashi T., Neve R., Takamiya K., and others.2009. Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat Neurosci12:879-87.
137.
Lisik MZ, Sieron AL2008. X-linked mental retardation. Med Sci Monit14:RA221-9.
138.
Liu B., Liao M., Mielke JG, Ning K., Chen Y., Li L., and others.2006. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci26:5309-19.
139.
Liu P., Cheng H., Roberts TM, Zhao JJ2009. Targeting the phosphoinositide 3-kinase pathway in cancer . Nat Rev Drug Discov8:627-44.
140.
Liu S., Lau L., Wei J., Zhu D., Zou S., Sun HS, and others.2004. Expression of Ca2+-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron43:43-55.
141.
Lloyd KM, Denis M.1963. Cowden’s disease: a possible new symptom complex with multiple system involvement. Ann Intern Med58:136-42.
142.
Lowry B., Miller JR, Fraser FC1971. A new dominant gene mental retardation syndrome. Association with small stature, tapering fingers, characteristic facies, and possible hydrocephalus. Am J Dis Child121:496-500.
143.
Lu W., Shi Y., Jackson AC, Bjorgan K., During MJ, Sprengel R., and others.2009. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron62:254-68.
144.
Lubs HA1969. A marker X chromosome. Am J Hum Genet21:231-44.
145.
Luscher C., Xia H., Beattie EC, Carroll RC, von Zastrow M., Malenka RC, and others.1999. Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron24:649-58.
146.
Luthi A., Chittajallu R., Duprat F., Palmer MJ, Benke TA, Kidd FL, and others.1999. Hippocampal LTD expression involves a pool of AMPARs regulated by the NSF-GluR2 interaction. Neuron24:389-99.
147.
Lynch NE, Lynch SA, McMenamin J., Webb D.2009. Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay. Arch Dis Child94: 553-4.
148.
Makino H., Malinow R.2009. AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis. Neuron64:381-90.
149.
Makita Y., Narumi Y., Yoshida M., Niihori T., Kure S., Fujieda K., and others.2007. Leukemia in cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. J Pediatr Hematol Oncol29:287-90.
150.
Malenka RC, Nicoll RA1999. Long-term potentiation-a decade of progress? Science285:1870-4.
151.
Malinow R., Malenka RC2002. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci25:103-26.
152.
Malleret G., Haditsch U., Genoux D., Jones MW, Bliss TV, Vanhoose AM, and others.2001. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin . Cell104:675-86.
153.
Mameli M., Balland B., Lujan R., Luscher C.2007. Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science317:530-3.
Margrie TW, Brecht M., Sakmann B.2002. In vivo, low-resistance, whole-cell recordings from neurons in the anaesthetized and awake mammalian brain. Pflugers Arch444:491-8.
156.
Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, and others.1999. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet8:1461-72.
157.
Martin JP, Bell J.1943. A pedigree of mental defect showing sex linkage. J Neurol Psychiatry6:154-7.
158.
Matsuda S., Launey T., Mikawa S., Hirai H.2000. Disruption of AMPA receptor GluR2 clusters following long-term depression induction in cerebellar Purkinje neurons. EMBO J19: 2765-74.
159.
Matsuo N., Reijmers L., Mayford M.2008. Spine-type-specific recruitment of newly synthesized AMPA receptors with learning. Science319:1104-7.
McKay MM, Morrison DK2007. Integrating signals from RTKs to ERK/MAPK. Oncogene26:3113-21.
162.
Mei L., Xiong WC2008. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci9: 437-52.
163.
Meng J., Meng Y., Hanna A., Janus C., Jia Z.2005. Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J Neurosci25:6641-50.
164.
Meng Y., Zhang Y., Jia Z.2003. Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron39:163-76.
165.
Meredith RM, Holmgren CD, Weidum M., Burnashev N., Mansvelder HD2007. Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile x gene FMR1 . Neuron54:627-38.
166.
Mochizuki N., Yamashita S., Kurokawa K., Ohba Y., Nagai T., Miyawaki A., and others.2001. Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature411:1065-8.
167.
Moessner R., Marshall CR, Sutcliffe JS, Skaug J., Pinto D., Vincent J., and others.2007. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet81:1289-97.
168.
Mor A., Philips MR2006. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol24:771-800.
169.
Mulkey RM, Herron CE, Malenka RC1993. An essential role for protein phosphatases in hippocampal long-term depression. Science261:1051-5.
170.
Murakoshi H., Iino R., Kobayashi T., Fujiwara T., Ohshima C., Yoshimura A., and others.2004. Single-molecule imaging analysis of Ras activation in living cells. Proc Natl Acad Sci U S A101:7317-22.
171.
Nadif Kasri N., Nakano-Kobayashi A., Malinow R., Li B., Van Aelst L.2009. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev23:1289-302.
172.
Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H., and others.1997. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet6:1383-7.
173.
Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A., and others.2006. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet38:294-6.
174.
Nimchinsky EA, Oberlander AM, Svoboda K.2001. Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci21:5139-46.
175.
Nishimune A., Isaac JT, Molnar E., Noel J., Nash SR, Tagaya M., and others.1998. NSF binding to GluR2 regulates synaptic transmission. Neuron21:87-97.
176.
Noonan JA, Ehmke DA1963. Associated noncardiac malformations in children with congenital heart disease. J Pediatr63:468-70.
177.
Norris CM, Kadish I., Blalock EM, Chen KC, Thibault V., Porter NM, and others.2005. Calcineurin triggers reactive/ inflammatory processes in astrocytes and is upregulated in aging and Alzheimer’s models. J Neurosci25:4649-58.
178.
O’Dell TJ, Kandel ER1994. Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases. Learn Mem1:129-39.
179.
O’Donnell WT, Warren ST2002. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci25:315-38.
Orloff MS, Eng C.2008. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene27: 5387-97.
182.
Osten P., Srivastava S., Inman GJ, Vilim FS, Khatri L., Lee LM, and others.1998. The AMPA receptor GluR2 C terminus can mediate a reversible, ATP- dependent interaction with NSF and alpha- and beta-SNAPs . Neuron21:99-110.
183.
Pagani MR, Oishi K., Gelb BD, Zhong Y.2009. The phosphatase SHP2 regulates the spacing effect for long-term memory induction. Cell139:186-98.
184.
Pandit B., Sarkozy A., Pennacchio LA, Carta C., Oishi K., Martinelli S., and others.2007. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet39:1007-12.
185.
Paradee W., Melikian HE, Rasmussen DL, Kenneson A., Conn PJ, Warren ST1999. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience94:185-92.
186.
Park M., Penick EC, Edwards JG, Kauer JA, Ehlers MD2004. Recycling endosomes supply AMPA receptors for LTP. Science305:1972-5.
187.
Park M., Salgado JM, Ostroff L., Helton TD, Robinson CG, Harris KM, and others.2006. Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron52:817-30.
188.
Passafaro M., Piech V., Sheng M.2001. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci4:917-26.
189.
Patrick GN, Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai LH1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature402: 615-22.
190.
Perriard J., Saurat JH, Harms M.2000. An overlap of Cowden’s disease and Bannayan-Riley-Ruvalcaba syndrome in the same family. J Am Acad Dermatol42:348-50.
191.
Petrini EM, Lu J., Cognet L., Lounis B., Ehlers MD, Choquet D.2009. Endocytic trafficking and recycling maintain a pool of mobile surface AMPA receptors required for synaptic potentiation. Neuron63:92-105.
192.
Pfeiffer BE, Huber KM2009. The state of synapses in fragile X syndrome. Neuroscientist15:549-67.
193.
Piccini A., Malinow R.2002. Critical postsynaptic density 95/ disc large/zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J Neurosci22:5387-92.
194.
Pilarski R.2009. Cowden syndrome: a critical review of the clinical literature . J Genet Couns18:13-27.
195.
Plowman SJ, Muncke C., Parton RG, Hancock JF2005. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton . Proc Natl Acad Sci U S A102:15500-5.
196.
Price DL, Sisodia SS1998. Mutant genes in familial Alzheimer’s disease and transgenic models. Annu Rev Neurosci21: 479-505.
197.
Qin Y., Zhu Y., Baumgart JP, Stornetta RL, Seidenman K., Mack V., and others.2005. State-dependent Ras signaling and AMPA receptor trafficking. Genes Dev19:2000-15.
198.
Rauen KA2007. HRAS and the Costello syndrome. Clin Genet71:101-8.
199.
Raymond CR, Redman SJ, Crouch MF2002. The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons. Neuroscience109: 531-6.
200.
Razzaque MA, Nishizawa T., Komoike Y., Yagi H., Furutani M., Amo R., and others.2007. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet39:1013-7.
201.
Renpenning H., Gerrard JW, Zaleski WA, Tabata T.1962. Familial sex-linked mental retardation. Can Med Assoc J87:954-6.
202.
Reynolds JF, Webb MJ, Opitz JM1986. A new autosomal dominant acrofacial dysostosis syndrome . Am J Med Genet Suppl2:143-50.
203.
Reynolds RM, Browning GG, Nawroz I., Campbell IW2003. Von Recklinghausen’s neurofibromatosis: neurofibromatosis type 1. Lancet361:1552-4.
204.
Riley HD, Smith WR1960. Macrocephaly, pseudopapilledema and multiple hemangiomata . Pediatrics26:293-300.
205.
Roberts A., Allanson J., Jadico SK, Kavamura MI, Noonan J., Opitz JM, and others.2006. The cardiofaciocutaneous syndrome. J Med Genet43:833-42.
206.
Roberts AE, Araki T., Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, and others.2007. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet39:70-4.
207.
Rodriguez-Viciana P., Tetsu O., Tidyman WE, Estep AL, Conger BA, Cruz MS, and others.2006. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science311:1287-90.
208.
Ropers HH2006. X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev16:260-9.
209.
Rubio ME, Wenthold RJ1997. Glutamate receptors are selectively targeted to postsynaptic sites in neurons. Neuron18: 939-50.
210.
Rumbaugh G., Adams JP, Kim JH, Huganir RL2006. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci U S A103: 4344-51.
211.
Rumpel S., LeDoux J., Zador A., Malinow R.2005. Postsynaptic receptor trafficking underlying a form of associative learning. Science308:83-8.
212.
Ruvalcaba RH, Myhre S., Smith DW1980. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet18:413-6.
213.
Sanderson DJ, Gray A., Simon A., Taylor AM, Deacon RM, Seeburg PH, and others.2007. Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory. Behav Neurosci121:559-69.
214.
Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW2002. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition. J Neurosci22:3376-85.
215.
Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ2007. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology68:1501-8.
216.
Schmitt WB, Arianpour R., Deacon RM, Seeburg PH, Sprengel R., Rawlins JN, and others.2004. The role of hippocampal glutamate receptor-A-dependent synaptic plasticity in conditional learning: the importance of spatiotemporal discontiguity. J Neurosci24:7277-82.
217.
Schmitt WB, Sprengel R., Mack V., Draft RW, Seeburg PH, Deacon RM, and others.2005. Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci8:270-2.
218.
Schoepfer R., Monyer H., Sommer B., Wisden W., Sprengel R., Kuner T., and others.1994. Molecular biology of glutamate receptors . Prog Neurobiol42:353-7.
219.
Schubbert S., Bollag G., Shannon K.2007. Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev17:15-22.
220.
Schubbert S., Zenker M., Rowe SL, Boll S., Klein C., Bollag G., and others.2006. Germline KRAS mutations cause Noonan syndrome. Nat Genet38:331-6.
221.
Schultz-Pedersen S., Hasle H., Olsen JH, Friedrich U.2001. Evidence of decreased risk of cancer in individuals with fragile X. Am J Med Genet103:226-30.
222.
Schulz AL, Albrecht B., Arici C., van der Burgt I., Buske A., Gillessen-Kaesbach G., and others.2008. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. Clin Genet73:62-70.
223.
Seidenman KJ, Steinberg JP, Huganir R., Malinow R.2003. Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells . J Neurosci23:9220-8.
224.
Senawong T., Phuchareon J., Ohara O., McCormick F., Rauen KA, Tetsu O.2008. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options . Hum Mol Genet17:419-30.
225.
Shalin SC, Egli R., Birnbaum SG, Roth TL, Levenson JM, Sweatt JD2006. Signal transduction mechanisms in memory disorders. Prog Brain Res157:25-41.
226.
Shepherd JD, Huganir RL2007. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol23:613-43.
227.
Shi S., Hayashi Y., Esteban JA, Malinow R.2001. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell105:331-43.
228.
Shi SH, Hayashi Y., Petralia RS, Zaman SH, Wenthold RJ, Svoboda K., and others.1999. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science284:1811-6.
229.
Shimshek DR, Jensen V., Celikel T., Geng Y., Schupp B., Bus T., and others.2006. Forebrain-specific glutamate receptor B deletion impairs spatial memory but not hippocampal field long-term potentiation . J Neurosci26:8428-40.
230.
Skinner M., Hooper S., Hatton DD, Roberts J., Mirrett P., Schaaf J., and others.2005. Mapping nonverbal IQ in young boys with fragile X syndrome. Am J Med Genet A132:25-32.
231.
Song I., Kamboj S., Xia J., Dong H., Liao D., Huganir RL1998. Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron21:393-400.
232.
Tada T., Sheng M.2006. Molecular mechanisms of dendritic spine morphogenesis . Curr Opin Neurobiol16:95-101.
233.
Takahashi T., Svoboda K., Malinow R.2003. Experience strengthening transmission by driving AMPA receptors into synapses. Science299:1585-8.
Tan HY, Nicodemus KK, Chen Q., Li Z., Brooke JK, Honea R., and others.2008. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans . J Clin Invest118:2200-8.
236.
Tang SJ, Reis G., Kang H., Gingras AC, Sonenberg N., Schuman EM2002. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci U S A99:467-72.
237.
Tartaglia M., Mehler EL, Goldberg R., Zampino G., Brunner HG, Kremer H., and others.2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet29:465-8.
238.
Tartaglia M., Pennacchio LA, Zhao C., Yadav KK, Fodale V., Sarkozy A., and others.2007. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet39:75-9.
239.
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL2005. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci8:1727-34.
240.
Thomas GM, Huganir RL2004. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci5:173-83.
241.
Thomas GM, Rumbaugh GR, Harrar DB, Huganir RL2005. Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission. Proc Natl Acad Sci U S A102:15006-11.
242.
Tian T., Harding A., Inder K., Plowman S., Parton RG, Hancock JF2007. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nat Cell Biol9:905-14.
243.
Tian X., Gotoh T., Tsuji K., Lo EH, Huang S., Feig LA2004. Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J23:1567-75.
244.
Tidyman WE, Rauen KA2008. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Expert Rev Mol Med10:e37.
245.
Tischmeyer W., Schicknick H., Kraus M., Seidenbecher CI, Staak S., Scheich H., and others.2003. Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory. Eur J Neurosci18:942-50.
246.
Tomita S., Stein V., Stocker TJ, Nicoll RA, Bredt DS2005. Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron45:269-77.
247.
Toth K., McBain CJ1998. Afferent-specific innervation of two distinct AMPA receptor subtypes on single hippocampal interneurons. Nat Neurosci1:572-8.
248.
Touraine RL, Zeniou M., Hanauer A.2002. A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome. Eur J Pediatr161:179-87.
249.
Trivier E., De Cesare D., Jacquot S., Pannetier S., Zackai E., Young I., and others.1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature384:567-70.
250.
Vaccarino FM, Grigorenko EL, Smith KM, Stevens HE2009. Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism. J Autism Dev Disord39:511-20.
251.
Van Dam D., D’Hooge R., Hauben E., Reyniers E., Gantois I., Bakker CE, and others.2000. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res117:127-36.
252.
van Os J., Kapur S.2009. Schizophrenia. Lancet374:635-45.
253.
van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., and others.1997. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science277:805-8.
254.
van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S., de Avila Freire R., and others.2007. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci10:280-2.
255.
Vivanco I., Sawyers CL2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer2:489-501.
256.
Vyazovskiy VV, Cirelli C., Pfister-Genskow M., Faraguna U., Tononi G.2008. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci11:200-8.
257.
Wagner EF, Nebreda AR2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer9:537-49.
258.
Wan PT, Garnett MJ, Roe SM, Lee S., Niculescu-Duvaz D., Good VM, and others.2004. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell116:855-67.
259.
Wang YT, Linden DJ2000. Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis. Neuron25:635-47.
260.
Wang Z., Edwards JG, Riley N., Provance DW, Jr., Karcher R., Li XD, and others.2008. Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity. Cell135:535-48.
261.
Waskiewicz AJ, Flynn A., Proud CG, Cooper JA1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. Embo J16:1909-20.
262.
Weeber EJ, Jiang YH, Elgersma Y., Varga AW, Carrasquillo Y., Brown SE, and others.2003. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome . J Neurosci23:2634-44.
263.
Wenthold RJ, Petralia RS, Blahos J., II, Niedzielski AS1996. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci16:1982-9.
264.
Williams VC, Lucas J., Babcock MA, Gutmann DH, Korf B., Maria BL2009. Neurofibromatosis type 1 revisited. Pediatrics123:124-33.
265.
Wong KK2009. Recent developments in anti-cancer agents targeting the Ras/Raf/MEK/ERK pathway. Recent Pat Anti-cancer Drug Discov4:28-35.
266.
Woo RS, Li XM, Tao Y., Carpenter-Hyland E., Huang YZ, Weber J., and others.2007. Neuregulin-1 enhances depolarization-induced GABA release. Neuron54:599-610.
267.
Wright N., Glazewski S., Hardingham N., Phillips K., Pervolaraki E., Fox K.2008. Laminar analysis of the role of GluR1 in experience-dependent and synaptic depression in barrel cortex. Nat Neurosci11:1140-2.
268.
Wu Y., Arai AC, Rumbaugh G., Srivastava AK, Turner G., Hayashi T., and others.2007. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc Natl Acad Sci U S A104:18163-8.
Yang Y., Wang XB, Frerking M., Zhou Q.2008. Delivery of AMPA receptors to perisynaptic sites precedes the full expression of long-term potentiation. Proc Natl Acad Sci U S A105:11388-93.
271.
Yashiro K., Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R., and others.2009. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci200912:777-83. Epub 2009 May 10.
272.
Yasuda H., Barth AL, Stellwagen D., Malenka RC2003. A developmental switch in the signaling cascades for LTP induction. Nat Neurosci6:15-6.
273.
Yasuda R., Harvey CD, Zhong H., Sobczyk A., van Aelst L., Svoboda K.2006. Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging. Nat Neurosci9:283-91.
274.
Yntema HG, van den Helm B., Kissing J., van Duijnhoven G., Poppelaars F., Chelly J., and others.1999. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics62:332-43.
275.
Yudowski GA, Puthenveedu MA, Leonoudakis D., Panicker S., Thorn KS, Beattie EC, and others.2007. Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors. J Neurosci27:11112-21.
276.
Zamanillo D., Sprengel R., Hvalby O., Jensen V., Burnashev N., Rozov A., and others.1999. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science284:1805-11.
277.
Zeke A., Lukacs M., Lim WA, Remenyi A.2009. Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol19:364-74.
278.
Zenker M., Lehmann K., Schulz AL, Barth H., Hansmann D., Koenig R., and others.2007. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet44:131-5.
279.
Zhao MG, Toyoda H., Ko SW, Ding HK, Wu LJ, Zhuo M.2005. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci25:7385-92.
280.
Zhou Q., Tao HW, Poo MM2003. Reversal and stabilization of synaptic modifications in a developing visual system. Science300:1953-7.
281.
Zhu JJ2000. Maturation of layer 5 neocortical pyramidal neurons: amplifying salient layer 1 and layer 4 inputs by Ca2+ action potentials in adult rat tuft dendrites. J Physiol (Lond) 526:571-87.
Zhu JJ, Malinow R.2002. Acute versus chronic NMDA receptor blockade and synaptic AMPA receptor delivery. Nat Neurosci5:513-4.
286.
Zhu JJ, Qin Y., Zhao M., Van Aelst L., Malinow R.2002. Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell110:443-55.
287.
Zhu X., Raina AK, Lee HG, Casadesus G., Smith MA, Perry G.2004a. Oxidative stress signalling in Alzheimer’s disease . Brain Res1000:32-9.
288.
Zhu X., Raina AK, Perry G., Smith MA2004b. Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol3:219-26.
289.
Zhu Y., Pak D., Qin Y., McCormack SG, Kim MJ, Baumgart JP, and others.2005. Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron46:905-16.
290.
Zhuo M., Zhang W., Son H., Mansuy I., Sobel RA, Seidman J., and others.1999. A selective role of calcineurin aalpha in synaptic depotentiation in hippocampus. Proc Natl Acad Sci U S A96:4650-5.
291.
Zonana J., Rimoin DL, Davis DC1976. Macrocephaly with multiple lipomas and hemangiomas. J Pediatr89:600-3.
